Carolyn Magill, Define Ventures partner
March 11, 2025 08:00 AM EDT
People
Health Tech

Ex­clu­sive: De­fine Ven­tures hires for­mer Ae­tion CEO Car­olyn Mag­ill

Lydia Ramsey Pflanzer

Deputy Editor

For­mer Ae­tion CEO Car­olyn Mag­ill has joined dig­i­tal health ven­ture firm De­fine Ven­tures as a ven­ture part­ner.

It’s the third big hire for De­fine over …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

TRENDING NOW

Up­dat­ed: Zealand part­ners with Roche on its amylin ana­log in a deal worth up to $5.3B

Ono li­cens­es rare blood dis­ease drug from Io­n­is for $280M up­front

Leg­end to dou­ble Carvyk­ti pro­duc­tion as it tar­gets block­buster sta­tus 

FDA’s med­ical re­view de­part­ments re­main un­touched (for now) by Musk’s cuts

Mer­ck scores a win in Gar­dasil cas­es af­ter judge says plain­tiffs’ ev­i­dence ‘falls far short’

sponsored

Obe­si­ty drug de­vel­op­ment—still room to grow

A service from the Financial Times